221 Objectives: 18F-flurpiridaz (FPZ) is a new PET perfusion tracer with close to 100%
extraction fraction during the first-pass transit through the coronary circulation. High tracer …

The novel PET flow tracer flurpiridaz F 18 shows high myocardial extraction and slow
washout. flurpiridaz F 18 PET data analysis with tracer kinetic modeling provides accurate …

Background 18 F-Flurpiridaz is a promising investigational radiotracer for PET myocardial
perfusion imaging with favorable properties for quantification of myocardial blood flow …

655 Objectives: 18 F-Flurpiridaz (FPZ) is a novel radiotracer for myocardial perfusion PET
currently undergoing late stage clinical trials [1-3]. We have recently demonstrated the …

1114 Objectives Flurpiridaz F-18 is a new PET myocardial perfusion tracer that is currently
undergoing clinical evaluation. We investigated the feasibility of streamlined quantification of …

Absolute quantitation of myocardial blood flow (MBF) by PET is an established method of
analyzing coronary artery disease (CAD) but subject to the various shortcomings of …

516 Objectives New 18 F-labeled myocardial blood flow (MBF) agents are becoming
available but the~ 2 hour half-life of 18 F complicates clinical application for rest/stress …

The new PET tracer, 18 F-flurpiridaz, with high myocardial extraction allows quantitative
myocardial blood flow (MBF) estimation from dynamic PET data and tracer kinetic modeling …

22 Background: 18F-flurpiridaz is a promising PET agent for myocardial perfusion imaging
(MPI), but with the long half-life attention needs to be paid to the rest/stress imaging due to …

P1072 Introduction: Coronary artery disease (CAD) is the leading cause of morbidity and
mortality worldwide; however, non-invasive assessment of CAD still remains a challenging …